Yarrow Bioscience, Inc. (YARW) Cash Flow Statement
Yarrow Bioscience, Inc. (YARW) generated -$16.9M of operating cash flow over the twelve months to 2026-06-30, spent $0 on capital expenditure and had free cash flow of -$16.9M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
YARWYarrow Bioscience, Inc.Follow YARW — free
—
Price chart with a free account
- Market cap
- 51.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2018 Dec 18 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -68.7 | -137.1 | -56.4 | -29.2 | -25.3 | -34.0 | -33.1 | -16.9 | |
| Capital expenditure | 0.6 | 0.1 | 0.0 | — | — | 0.1 | 0.0 | -0.0 | |
| Free cash flow | -69.2 | -137.2 | -56.4 | — | — | -34.1 | -33.1 | -16.9 | |
| Stock-based compensation | 5.3 | 18.1 | 8.1 | 4.3 | 3.3 | 3.3 | 2.3 | — |
USD millions · SEC XBRL
Yarrow Bioscience, Inc. — questions
- What is Yarrow Bioscience, Inc.'s operating cash flow?
- -$16.9M over the twelve months to 2026-06-30.
- How much does Yarrow Bioscience, Inc. spend on capital expenditure?
- $0 over the twelve months to 2026-06-30.
- What is Yarrow Bioscience, Inc.'s free cash flow?
- -$16.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Yarrow Bioscience, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.